The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Loan | Alive

Total Raised


Last Raised

$680K | 2 yrs ago

About Intelligent Retinal Imaging Systems

Intelligent Retinal Imaging Systems (IRIS) develops a retinal telemedicine assessment service based on technology developed at the Florida Institute for Human and Machine Cognition. IRIS's technology is targeted at preventing two of the leading causes of blindness in adults: diabetic retinopathy and glaucoma. IRIS's systems were developed by retina specialty physicians to more efficiently diagnose the early stages of preventable eye disease, giving patients and physicians unprecedented access to drive quality outcomes and reduce the cost of care.

Intelligent Retinal Imaging Systems Headquarter Location

2 N Palafox Street Suite 200

Pensacola, Florida, 32502,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Intelligent Retinal Imaging Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Intelligent Retinal Imaging Systems is included in 4 Expert Collections, including Diabetes.



1,750 items


Digital Health

12,794 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)



2,789 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.


Medical Devices

3,286 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Latest Intelligent Retinal Imaging Systems News

Intelligent Retinal Imaging Systems (IRIS) Partners with Remidio Innovative Solutions to Provide Early Detection Systems for Diabetic Eye Disease

Oct 11, 2019

Intelligent Retinal Imaging Systems (IRIS) announced a partnership with Remidio Innovative Solutions to bring their smartphone based non-mydriatic fundus camera to the U.S. market. Coupling the IRIS software and services program with an affordable and high-quality handheld camera will allow more service providers to successfully adopt a telemedicine program into their practices to examine, detect and diagnose retinal disease in diabetic patients, according to a company news release. “The IRIS and Remidio partnership will have a powerful impact on healthcare providers seeking to close care gaps and create better outcomes for their patients with diabetes,” Steve Martin, CEO of IRIS, said in a company news release. “The Remidio device is portable, affordable and takes high quality images, which supported by the IRIS algorithms will make it much easier to provide sight-saving exams to patients with diabetes.” The Remidio portable, smartphone based fundus cameras have been validated against high-end desktop imaging systems, in peer reviewed publications in PLOSOne, Nature Eye, Ophthalmology Retina, JAMA Ophthalmology, to name a few. The use of artificial intelligence (AI) is enhancing the way retinal screenings can prevent blindness. The Remidio camera provides cutting edge, AI-ready capabilities, such as providing instantaneous image gradeability on the camera, so that the end user knows if the image is able to be graded for diagnosis. This is a critical feature, as the industry is moving to providing retinal exams in settings where there is limited connectivity, such as people’s home, on buses where screenings are performed, at screening events, as well as office settings. Partnering the capabilities of the IRIS and Remidio teams together will allow for collaboration on ways their combined technologies can improve diagnosing disease and preventing blindness. IRIS was created for early identification of diabetes in patients to improve outcomes and to reduce downstream healthcare costs. This comprehensive solution, which just surpassed the milestone of performing over 500,000 patient exams, includes simple to use cameras, a secure, HIPAA compliant software platform, and a seamless electronic medical record (EMR) integration providing accurate diagnoses back to the ordering physician. Unlike others in the retinal telemedicine space, IRIS is the only solution that offers the highest gradeability rate in the industry, due in part to the caliber of the cameras, like Remidio, but also as a result of in-depth camera training and proprietary algorithms that IRIS has developed to enhance the images and allow for an effective diagnosis to be performed. Remidio is an ISO13485-certified integrated medical device and artificial intelligence company seeking to enhance healthcare access by creating technologies that are smart and easy to use. “By partnering with IRIS, we are part of a complete program that aligns and supports the IRIS mission to challenge the status quo, empower providers to face changing practice patterns, and deliver early detection of diabetic eye disease in primary care,” Dr. Anand Sivaraman, CEO of Remidio Innovative Solutions, said in the news release. “This partnership is coming at the right time, with the per patient annual cost of managing diabetes at over $13,000 in the United states. We seek to bring this cost down by 30% through early detection, management, and treatment, with IRIS using Remidio non-mydriatic fundus on phone cameras.” Recent Content

Intelligent Retinal Imaging Systems Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Intelligent Retinal Imaging Systems Rank

You May Also Like

Verily Life Sciences Logo
Verily Life Sciences

Verily Life Sciences develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. The company partners with leading life sciences, medical device and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.

Remidio Logo

Remidio is an ophthalmic products company that offers products at affordable prices. The company's vision is to bring to market ophthalmic devices that are affordable, easy-to-use, and built with a larger aim of tackling avoidable blindness in resource-starved situations.

Retinai Logo

Retinai supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence. Its vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as age-related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. Its solutions rely on advances in medical image analysis, opthalmology, and machine learning.

Skin Analytics

Skin Analytics is a self-screening service for web and mobile that detects changes in moles. A small change in a mole is a key early warning sign for melanoma. Using a smartphone or digital camera photos can be uploaded to the website or mobile app. Our patent-pending image processing software corrects for differences in angle, lighting and focal length. By comparing mole images over time, our system can alert users to a change in a mole and prompt them to seek help earlier. Early detection is essential in melanoma. An increase in the depth of the cancer of just 1/10th of a millimetre can reduce survival by 30%. Our service makes mole mapping easy, detects subtle changes, and helps users to get in the habit of checking their skin.

Eyenuk Logo

Eyenuk is focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and preserving their vision. Using computer vision and image analysis expertise, the company is developing a portfolio of products based on its proprietary retinal image analysis technology to identify and track the progression of eye diseases including diabetic retinopathy and age-related macular degeneration.

AEYE Health Logo
AEYE Health

AEYE Health is a digital health company that aims to enable automated, AI-based diagnostic screening solutions for retinal imaging.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.